BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2669670)

  • 1. [Macroprolactinoma resistant to bromocriptine].
    López-Espinosa E; Ayala AR; Grimaldo J; Kunhardt J; Villanueva C
    Arch Invest Med (Mex); 1989; 20(1):1-8. PubMed ID: 2669670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
    Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
    Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Macroprolactinoma reduction and pregnancy induction with bromocriptine].
    Grimaldo J; López Espinoza E; Villanueva C; Verulo Reyes TB; Ayala AR
    Ginecol Obstet Mex; 1988 Aug; 56():213-7. PubMed ID: 3154241
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
    Pereira JL; García-Luna PP; Leal-Cerro A; Cortés A; Trujillo F; Villamil F; Vaquero F; Revuelta M; Astorga R
    Med Clin (Barc); 1994 Jun; 103(2):59-64. PubMed ID: 8051973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The best approach to treat prolactinoma].
    Zárate A; Saucedo R; Basurto L
    Gac Med Mex; 2004; 140(5):567-9. PubMed ID: 15559242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR; Sheppard MC; Heath DA
    Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.
    Iyer P; Molitch ME
    Endocr Pract; 2011; 17(3):e55-8. PubMed ID: 21324816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactorrhea in a 14-year-old girl.
    Panamonta O; Pakawut N
    J Med Assoc Thai; 2006 Aug; 89(8):1304-7. PubMed ID: 17048445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late development of resistance to bromocriptine in a patient with macroprolactinoma.
    Delgrange E; Crabbé J; Donckier J
    Horm Res; 1998; 49(5):250-3. PubMed ID: 9568811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiasmal herniation as a complication of bromocriptine therapy.
    Taxel P; Waitzman DM; Harrington JF; Fagan RH; Rothfield NF; Chen HH; Malchoff CD
    J Neuroophthalmol; 1996 Dec; 16(4):252-7. PubMed ID: 8956160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case].
    García Calzado MC; Ruiz Buendía A
    Rev Clin Esp; 1992 Jun; 191(2):112-3. PubMed ID: 1502384
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to bromocriptine in prolactinomas.
    Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of fertility in an infertile man with resistant macroprolactinoma using high-dose bromocriptine and a combination of human chorionic gonadotropin and an aromatase inhibitor.
    Heidari Z; Hosseinpanah F; Shirazian N
    Endocr Pract; 2010; 16(4):669-72. PubMed ID: 20439242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.